Accotest(SH:688200)2024-04-25 12:08Financial Performance - The company's operating revenue for Q1 2024 was ¥136,823,208.53, representing a decrease of 31.61% compared to the same period last year[3]. - The net profit attributable to shareholders was ¥23,438,331.42, down 68.62% year-on-year, primarily due to industry fluctuations affecting core business revenue[3][17]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥31,829,980.34, a decline of 55.20% compared to the previous year[3][17]. - The basic earnings per share decreased by 69.09% to ¥0.17[3][17]. - The diluted earnings per share also decreased by 69.09% to ¥0.17[4][17]. - The total comprehensive income for the first quarter of 2024 is ¥23,227,165.95, significantly lower than ¥101,685,172.48 in the previous year[46]. - Net profit for Q1 2024 was CNY 23,438,331.42, a decline of 68.7% compared to CNY 74,690,932.45 in Q1 2023[26]. Cash Flow - The net cash flow from operating activities was negative at -¥8,028,380.20, a decrease of 114.99% year-on-year, mainly due to reduced cash received from sales[3][17]. - Cash flow from operating activities showed a net outflow of CNY 8,028,380.20 in Q1 2024, compared to a net inflow of CNY 53,574,763.62 in Q1 2023[29]. - In Q1 2024, cash inflow from operating activities totaled approximately $137.19 million, a decrease of 41.4% compared to $234.83 million in Q1 2023[47]. - Cash received from sales of goods and services was approximately $126.48 million, down from $217.07 million in the same period last year, indicating a decline of 41.6%[47]. - The cash received from tax refunds was approximately $5.19 million, a decrease of 60.8% compared to $13.23 million in Q1 2023[47]. - Cash received from other operating activities increased to approximately $5.51 million, up 21.5% from $4.53 million in Q1 2023[47]. - Cash paid for purchasing goods and services was approximately $43.83 million, down 16.8% from $52.68 million in Q1 2023[47]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,478,210,365.82, an increase of 0.33% from the end of the previous year[4]. - Total assets as of March 31, 2024, are ¥3,478,210,365.82, compared to ¥3,466,864,543.70 at the end of 2023[40]. - The company's cash and cash equivalents as of March 31, 2024, amount to ¥1,992,227,072.31, a decrease from ¥2,026,798,829.38 as of December 31, 2023[38]. - Accounts receivable increased to ¥290,707,435.51 from ¥262,778,697.01, indicating a growth of approximately 10.4%[40]. - Inventory as of March 31, 2024, is ¥151,004,572.13, up from ¥141,630,115.69, reflecting an increase of about 6.5%[40]. - The company reported a decrease in trading financial assets to ¥78,874,532.14 from ¥93,693,534.03[38]. Research and Development - The company's R&D investment totaled ¥34,785,458.24, an increase of 4.88%, accounting for 25.42% of operating revenue, up 8.84 percentage points[4][17]. - Research and development expenses increased to CNY 34,785,458.24 in Q1 2024, up from CNY 33,167,343.28 in Q1 2023, reflecting a growth of 4.9%[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 7,332[36]. - The largest shareholder, Tianjin Xinhua Investment Holding Co., Ltd., holds 37,236,420 shares, accounting for 27.51%[36]. - The company has no significant changes in the top 10 shareholders due to margin trading or securities lending[37]. Expenses - Total operating costs for Q1 2024 were CNY 105,277,976.12, down 20.4% from CNY 132,294,060.05 in Q1 2023[24]. - The company reported a decrease in sales expenses to CNY 33,747,158.08 in Q1 2024, compared to CNY 28,567,848.36 in Q1 2023, indicating a rise of 18.3%[24]. - The company recorded a financial expense of CNY -12,762,790.36 in Q1 2024, compared to CNY -6,973,850.89 in Q1 2023, reflecting an increase in financial costs[24]. Non-Recurring Items - The company recognized non-recurring losses of -¥8,391,648.92 during the reporting period, primarily due to fair value changes in financial assets and liabilities[15].